drugset / Trial / NCT00515281
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine whether inhaled nitric oxide improves the neurological outcome for premature infants.
Timeline
- Start
- 2008-05
- Primary completion
- 2023-06-07
- Completion
- 2023-11-28
Publications
- Background Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med. 2003 Nov 27;349(22):2099-107. doi: 10.1056/NEJMoa031154.
- Background Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med. 2005 Jul 7;353(1):23-32. doi: 10.1056/NEJMoa043514.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | — | Inhaled |
| Background | Oxygen | Other / unclassified | — | — |